International Women’s Day

We believe in high performing teams...

We believe in high performing teams – regardless of what year they were born, what country they were born in, or what chromosomes they were born with.

So today we celebrate the female founders that inspire us everyday to continue to do our part to close the gender equity (and equality) gap in tech.

Alexandra Zatarain, Co-founder at Eight Sleep

Zatarian’s startup, Eight, takes the online mattress-selling business one step further with a smart mattress that tracks your sleep lets you adjust each side for temperature and more. Prior to launching the San Francisco-based startup, Zatarian worked in public relations in New York City.

Melonee Wise, Founder of Fetch Robotics

Melonee Wise is the CEO of Fetch Robotics, which is delivering advanced robots for the logistics industry. Prior to Fetch, Melonee was CEO and co-founder of Unbounded Robotics. She was Manager of Robot Development at Willow Garage, where she led a team of engineers developing next-generation robot hardware, including the PR2 and TurtleBot. Melonee has extensive experience in the growth of ROS, the open source Robot Operating System, as a research and commercial platform. Melonee was a 2015 recipient of Technology Review's TR 35 – an award for leading technology innovators under the age of 35. Also, she was previously a mentor in the Qualcomm Robotics Accelerator program.

Sky Kelley, Founder and CEO of Avisare

Sky Kelley is Founder & CEO of Avisare, a company she began out of a desire to eradicate wealth and income inequality along racial and gender lines. Long an entrepreneur at heart, she held executive-level roles at Disney & ESPN and AT&T after founding her first start-up. Sky began her career on Wall Street, completing a graduate training program with UBS and assumed roles in Derivative Sales and Equity Sales-Trading covering technology, media and telecom in New York and London. Sky sits on the board of the LA Cleantech Incubator Diversity & Inclusion Committee as well as being a part of the Milken Institute’s Partnership for Lending in Underserved Markets (PLUM) Task Force. She holds a Bachelor of Arts degree from the University of North Carolina at Chapel Hill where she studied Entrepreneurship.

Falon Fatemi, Founder at Node

A Silicon Valley native and the child of two serial entrepreneurs, Falon Fatemi first gained prominence as Google’s youngest employee when she worked for the tech giant as a financial analyst at the age of 19. During that time, She realized that the web was full of hidden opportunities -- and set out to fix this critical problem by surfacing previously undiscovered links between businesses and people that could be used to connect them in new and profound ways.

Renée DiResta, Co-Founder of Haven

Renée was part of the founding team and ran marketing and business development at Haven, the transportation management technology platform that’s transforming trade logistics for commodity, CPG, and food shippers. Before that, Renée was a Principal at seed-stage venture capital fund O’Reilly AlphaTech Ventures (OATV), where she invested in early technology startups with a focus on hardware, manufacturing, and logistics companies. She spent seven years on Wall Street as an equity derivatives trader and market maker at Jane Street, a top quantitative proprietary trading firm in New York City.

Eileen Carey, Co-Founder and CEO of Glassbreakers

Eileen Carey is the Co-Founder & CEO of Glassbreakers, an enterprise software company that offers solutions for corporate diversity & inclusion.

She holds a B.A. in English from the University of Maryland College Park and an MBA in International Marketing from the Fordham Gabelli School of Business.

Kim Walpole, Founder of Trials.AI is Kim's 3rd company yet her passion for finding and fixing root problems with clinical trials drives her as if it were her first. Ms Walpole's knowledge of clinical trials grew as she built her first company working with Tier 1 Pharma companies like Merck, Pfizer and Genentech. Her mission is to leverage technology to help organizations fix the two root causes of failure in clinical trials: study design and execution. These problems cost trial sponsors billions of dollars per year and prevent much needed treatments from getting to patients faster.